Another COVID Wave in Europe? Adderall Shortage Warning; Human-Rat Brain Fusion

Note that some links may require subscriptions.

Europe appears to be entering another COVID-19 wave as cases begin to rise across the continent, according to the World Health Organization and the European Centres for Disease Prevention and Control. (Reuters)

Pfizer and its partner BioNTech reported its updated booster generated a strong immune response against the currently circulating BA.5 and the BA.4 subvariants of Omicron.

A Scottish study showed that 6 to 18 months after a COVID-19 infection, about 1 out of every 17 people had not recovered and 42% had only experienced partial recovery. (Nature Communications)

Black Medicare patients were less likely to receive a surgical consultation after being admitted with an emergency general surgery condition than similar white patients. (JAMA Surgery)

The FDA warned of a shortage of the immediate-release formulation of amphetamine mixed salts (Adderall), a drug approved for attention deficit hyperactivity disorder and narcolepsy, due to manufacturing delays.

A cholera outbreak in Haiti killed at least 18 persons and possibly infected hundreds more. (Reuters)

Pursuing wellness has become exhausting. (The Atlantic)

Implanting human stem cell-derived cortical organoids into rats may boost our understanding of brain disorders such as autism. (Nature)

The Bezos Family Foundation announced it is donating $710 million to the Fred Hutchinson Cancer Center in Seattle. (ABC News)

Health care costs are poised to become the next battleground in the Biden Administration’s war against inflation. (Politico)

Myron Rolle’s journey took him from professional football to a career in neurosurgery. (New York Times)

Here’s what the NFL’s latest concussion controversy and policy change mean. (NPR)

The federal Treasury Department is investigating whether Florida Gov. Ron DeSantis (R) misused COVID-19 pandemic aid money to fund the relocation of Venezuelan migrants from Texas to Massachusetts. (USA Today)

The NIH is participating in a clinical trial in the Democratic Republic of the Congo to evaluate the antiviral drug tecovirimat (TPOXX) in adults and children with monkeypox.

The Cooper Health System lost a bid to recoup $15 million related to its effort to acquire several New Jersey hospitals from Livonia, Michigan-based Trinity Health. (Philadelphia Inquirer)

U.S. Senate candidate John Fetterman sat down for his first one-on-one interview since having a stroke in May. (Today)

Is the “troubled teen industry” — an assortment of boot camps, wilderness therapy programs, therapeutic boarding schools, and residential treatment centers — effective in treating children’s mental health problems? (New York Times)

The Indiana Supreme Court issued a ruling allowing allow abortions to continue pending a court ruling on whether new abortion restrictions violate the state’s constitution. (Indianapolis Star)